| [1] |
崔书章, 寿松涛, 柴艳芬. 实用危重病医学[M]. 天津: 天津科学技术出版社, 2001: 913-920.
|
| [2] |
Moss M,Martin GS. A global perspective on the epidemiology of sepsis [J]. Intensive Care Med, 2004, 30(4): 527-529.
|
| [3] |
王秋卉,王锦权.脓毒症与肝细胞线粒体损伤[J].中国急救医学, 2007, 27(6): 561-563.
|
| [4] |
Slade E,Tamber PS,Vincent JL. The Surviving Sepsis Campaign: raising awareness to reduce mortality [J]. Crit Care, 2003, 7(1): 1-2.
|
| [5] |
van der Poll T,Opal SM. Host-pathogen interactions in sepsis [J]. Lancet Infect Dis, 2008, 8: 32-43.
|
| [6] |
Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS) [J]. Ann Intern Med, 1996, 125(8): 680-687.
|
| [7] |
Hotchkiss RS,Coopersmith CM,McDunn JE, et al. The sepsis see saw: tilting toward immunosuppression [J]. Nat Med, 2009, 15(5): 496-497.
|
| [8] |
Wiersinga WJ. Current insights in sepsis: from pathogenesis to new treatment targets [J]. Curr Opin Crit Care, 2011, 17(5): 480-486.
|
| [9] |
Słotwiński R,Słotwińska S,Kędziora S, et al. Innate immunity signaling pathways: links between immunonutrition and responses to sepsis [J]. Arch Immunol Ther Exp (Warsz), 2011, 59(2): 139-150.
|
| [10] |
Knapp S. Update on the role of Toll-like receptors during bacterial infections and sepsis [J]. Wien Med Wochenschr, 2010, 160(5-6): 107-111.
|
| [11] |
Salomao R,Brunialti MK,Rapozo MM, et al. Bacterial sensing, cell signaling, and modulation of the immune response during sepsis [J]. Shock, 2012, 38(3): 227-242.
|
| [12] |
Lee CC,Avalos AM,Ploegh HL. Accessory molecules for Toll-like receptors and their function [J]. Nat Rev Immunol, 2012, 12(3): 168-179.
|
| [13] |
Yang H,Wang H,Czura CJ, et al. The cytokine activity of HMGB1 [J]. J Leukoc Biol, 2005, 78(1): 1-8.
|
| [14] |
Zhang CC,Krieg S,Shapiro DJ. HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells [J]. Mol Endocrinol, 1999, 13(4): 632-643.
|
| [15] |
Wang H,Bloom O,Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice [J]. Science, 1999, 285(5425): 248-251.
|
| [16] |
Tracey KJ,Cerami A. Tumor necrosis factor in the malnutrition (cachexia) of infection and cancer [J]. Am J Trop Med Hyg, 1992, 47(1 Pt 2): 2-7.
|
| [17] |
Yang H,Ochani M,Li J, et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1 [J]. Proc Natl Acad Sci USA, 2004, 101(1): 296-301.
|
| [18] |
Treutiger CJ,Mullins GE,Johansson AS, et al. High mobility group 1 B-box mediates activation of human endothelium [J]. J Intern Med, 2003, 254(4): 375-385.
|
| [19] |
Sunden-Cullberg J,Norrby-Teglund A,Rouhiainen A, et al. Pers mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock [J]. Crit Care Med, 2005, 33(3): 564-573.
|
| [20] |
Chen G,Li J,Ochani M, et al. Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms [J]. J Leukoc Biol, 2004, 76(5): 994-1001.
|
| [21] |
Gibot S,Massin F,Cravoisy A, et al. High-mobility group box 1 protein plasma concentrations during septic shock [J]. Intensive Care Med, 2007, 33(8): 1347-1353.
|
| [22] |
Singh A,Boden G,Rao AK. Tissue factor and Toll-like receptor (TLR) 4 in hyperglycaemia-hyperinsulinaemia. Effects in healthy subjects, and type 1 and type 2 diabetes mellitus [J]. Thromb Haemost, 2015, 113(4): 750-758.
|
| [23] |
李雨泽,刘玉琴,陈向丽, 等. 2型糖尿病并发肺结核患者血清中炎症细胞因子水平变化的研究[J]. 中国防痨杂志, 2017, 39(2): 145-148.
|
| [24] |
Akira S,Takeda K. Toll-like receptor signalling [J]. Nat Rev Immunol, 2004, 4(7): 499-511.
|
| [25] |
Bruserud O. Bidirectional crosstalk between platelets and monocytes initiated by Toll-like receptor: an important step in the early defense against fungal infections? [J]. Platelets, 2013, 24(2): 85-97.
|
| [26] |
Kolek MJ,Carlquist JF,Muhlestein JB, et al. Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes [J]. Am Heart J, 2004, 148(6): 1034-1040.
|